5% Minoxidil Hair Regrowth Serum With Biotin Liquid
NDC 87394-001
Product Information
5% Minoxidil Hair Regrowth Serum With Biotin (minoxidil) is a OTC MONOGRAPH DRUG-approved product labeled by Shenzhen Huayuan Hengsheng Technology Co., Ltd.. Minoxidil is used with other medications to treat high blood pressure (hypertension). It is supplied as a liquid for topical administration. This product entry covers the primary NDC 87394-001 and 2 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 87394-001?
What are the uses of this product?
What are Active Ingredients of this product?
- MINOXIDIL .05 g/mL - A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- MINOXIDIL (UNII: 5965120SH1)
- MINOXIDIL (UNII: 5965120SH1) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ALCOHOL (UNII: 3K9958V90M)
- BIOTIN (UNII: 6SO6U10H04)
- WATER (UNII: 059QF0KO0R)
- BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
- GLYCERIN (UNII: PDC6A3C0OX)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 311724 - minoxidil 5 % Topical Solution
- RxCUI: 311724 - minoxidil 50 MG/ML Topical Solution
- RxCUI: 311724 - minoxidil 3 GM per 60 ML Topical Solution
- RxCUI: 311724 - minoxidil 5 GM per 100 ML Topical Solution
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.